GO:0004777 succinate-semialdehyde dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004777 describes the NAD+-dependent oxidation of succinate semialdehyde to succinate, a key step in GABA and 4-aminobutyrate catabolism.
• The reaction consumes NAD+ and water and produces succinate, NADH and H+, linking the pathway to cellular redox and energy metabolism.
• In Escherichia coli, the yneI gene encodes an NAD+/NADP+-dependent succinate semialdehyde dehydrogenase, while gabD encodes the NADP+-preferring enzyme.
• Human succinic semialdehyde dehydrogenase (ALDH5A1) is a mitochondrial enzyme whose active-site network of titratable residues guides catalysis and NAD+ binding.
• Loss of succinate semialdehyde dehydrogenase activity causes accumulation of succinate semialdehyde and 4-hydroxybutyrate, which is associated with neurological disease.
• Adaptive laboratory evolution can recruit the promiscuous activity of succinate semialdehyde dehydrogenase to repair different metabolic deficiencies.
Description
Succinate-semialdehyde dehydrogenase (NAD+) activity, classified as GO:0004777, catalyzes the NAD+-dependent oxidation of succinate semialdehyde to succinate with concomitant reduction of NAD+ to NADH. This molecular function is a central step in the catabolism of 4-aminobutyrate (GABA) and in pathways that feed succinate into the tricarboxylic acid cycle, making it relevant to microbial carbon and nitrogen metabolism as well as to human neurotransmitter turnover. The enzyme belongs to the aldehyde dehydrogenase superfamily and uses a conserved catalytic cysteine to form a thiohemiacetal intermediate with the aldehyde substrate. Researchers study GO:0004777 because it connects redox balance, GABA metabolism and mitochondrial energy production. In bacteria, the NAD+-dependent activity encoded by yneI and related genes supports growth on GABA or succinate semialdehyde as a carbon source. In humans, the orthologous enzyme ALDH5A1 is a mitochondrial NAD+-dependent dehydrogenase whose dysfunction leads to accumulation of succinate semialdehyde and 4-hydroxybutyrate, a condition known as succinic semialdehyde dehydrogenase deficiency. The catalytic mechanism involves an active-site network of titratable residues that guides NAD+ binding and catalysis. From a methods perspective, GO:0004777 can be assayed spectrophotometrically by monitoring NADH formation at 340 nm, and its histochemical detection has been critically evaluated in tissue sections. Purification and characterization studies in organisms such as potato tuber and Rhodopseudomonas spheroides have revealed both NAD+- and NADP+-dependent forms, highlighting the cofactor promiscuity of some homologs. This article summarizes the definition, mechanism, key genes, disease links and experimental models for GO:0004777.
succinate-semialdehyde dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0004777 |
|---|---|
| GO term | succinate-semialdehyde dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | succinate semialdehyde dehydrogenase activity; succinate-semialdehyde dehydrogenase activity; succinate semialdehyde:NAD+ oxidoreductase activity; succinate-semialdehyde:NAD+ oxidoreductase activity; succinic semialdehyde dehydrogenase activity; succinyl semialdehyde dehydrogenase activity |
| Definition | Catalysis of the reaction: succinate semialdehyde + NAD+ + H2O = succinate + NADH + H+. |
| Major function | NAD+-dependent oxidation of succinate semialdehyde to succinate, a step in GABA/4-aminobutyrate catabolism and succinate supply. |
| Cofactor | NAD+ as the electron acceptor; some homologs also accept NADP+. |
| Subcellular context | In humans, the orthologous enzyme ALDH5A1 is mitochondrial. |
| Representative genes | Escherichia coli yneI and gabD; human ALDH5A1. |
What Is GO:0004777?
GO:0004777 succinate-semialdehyde dehydrogenase (NAD+) activity is a molecular function defined as the catalysis of the reaction: succinate semialdehyde + NAD+ + H2O = succinate + NADH + H+. In other words, the enzyme oxidizes the aldehyde group of succinate semialdehyde to a carboxylate, using NAD+ as the electron acceptor and water as the oxygen donor, and releases succinate, NADH and a proton. The term is specific to NAD+-dependent catalysis, distinguishing it from NADP+-dependent succinate-semialdehyde dehydrogenase activities.
Why Is succinate-semialdehyde dehydrogenase (NAD+) activity Important in Cell Biology?
GO:0004777 is important because it sits at the intersection of GABA catabolism, redox homeostasis and mitochondrial energy metabolism. The NAD+-dependent oxidation of succinate semialdehyde to succinate provides a route for carbon entry into the tricarboxylic acid cycle and regenerates NADH, which feeds oxidative phosphorylation. In microorganisms, this activity supports growth on GABA or succinate semialdehyde as sole carbon and nitrogen sources, and its gene assignment has been verified experimentally in Escherichia coli. In humans, the enzyme encoded by ALDH5A1 is essential for detoxifying succinate semialdehyde derived from GABA transamination; impaired activity leads to accumulation of succinate semialdehyde and 4-hydroxybutyrate, which is associated with neurological dysfunction. The catalytic mechanism relies on an active-site network of titratable residues that guides NAD+ binding and catalysis, making it a model for aldehyde dehydrogenase enzymology.
• Provides a direct route for succinate semialdehyde to enter the tricarboxylic acid cycle as succinate.
• Supports microbial growth on GABA and succinate semialdehyde as carbon and nitrogen sources.
• Generates NADH, linking the reaction to cellular redox balance and energy metabolism.
• Human ALDH5A1 dysfunction causes accumulation of succinate semialdehyde and 4-hydroxybutyrate, associated with neurological disease.
• Serves as a model aldehyde dehydrogenase for studying catalytic cysteine chemistry and NAD+ binding.
• Shows cofactor promiscuity in some homologs, accepting both NAD+ and NADP+.
• Can be recruited by adaptive laboratory evolution to repair metabolic deficiencies.
• Histochemical and spectrophotometric assays enable detection in tissues and cell extracts.
• Purification from plant and bacterial sources has revealed diverse oligomeric and kinetic properties.
• Relevant to metabolic engineering of succinate and GABA-related pathways.
What Happens During succinate-semialdehyde dehydrogenase (NAD+) activity?
Substrate binding and cofactor selection
In simple terms: The enzyme first grabs its aldehyde substrate and an NAD+ molecule.
The reaction begins with binding of succinate semialdehyde and NAD+ in the active site. In the human enzyme ALDH5A1, an active-site network of titratable residues guides catalysis and NAD+ binding, ensuring that the correct cofactor is positioned for hydride transfer. In Escherichia coli, two distinct enzymes exist: one NAD+-dependent and one NADP+-dependent, allowing the cell to use different cofactors depending on metabolic conditions. Some bacterial homologs, such as the YneI protein from Salmonella typhimurium, can use both NAD+ and NADP+.
Thiohemiacetal formation and hydride transfer
In simple terms: A catalytic cysteine attacks the aldehyde, and a hydride is transferred to NAD+.
A conserved catalytic cysteine forms a thiohemiacetal intermediate with the aldehyde carbon of succinate semialdehyde. Hydride transfer from this intermediate to NAD+ produces NADH and a thioester intermediate. The active-site architecture of aldehyde dehydrogenases positions the nicotinamide ring and the substrate for efficient hydride transfer, and mutations in the titratable residue network can impair catalysis.
Hydrolysis and product release
In simple terms: Water breaks the intermediate, releasing succinate and NADH.
Hydrolysis of the thioester intermediate by water releases succinate and regenerates the free cysteine. The overall reaction consumes NAD+ and water and produces succinate, NADH and H+. In vivo, the NADH produced can be reoxidized by the respiratory chain, linking the activity to energy metabolism. The reaction is essentially irreversible under physiological conditions, favoring succinate formation.
Physiological context and pathway integration
In simple terms: This reaction helps cells use GABA and related molecules for energy.
In bacteria, succinate semialdehyde dehydrogenase activity is part of the GABA catabolic pathway, allowing growth on GABA or succinate semialdehyde as carbon and nitrogen sources. In humans, the mitochondrial enzyme ALDH5A1 converts succinate semialdehyde derived from GABA transamination to succinate, which can enter the tricarboxylic acid cycle. Adaptive laboratory evolution experiments have shown that the promiscuous activity of succinate semialdehyde dehydrogenase can be recruited to repair different metabolic deficiencies, underscoring its metabolic flexibility.
Key Genes Involved in GO:0004777 succinate-semialdehyde dehydrogenase (NAD+) activity
The following genes and proteins are experimentally linked to succinate-semialdehyde dehydrogenase (NAD+) activity or its close homologs.
| Gene | Major Role | Research Relevance |
|---|---|---|
| yneI (E. coli) | Encodes an NAD+/NADP+-dependent succinate semialdehyde dehydrogenase | Experimentally verified gene for the activity; used to study cofactor promiscuity |
| gabD (E. coli) | Encodes an NADP+-preferring succinate semialdehyde dehydrogenase | Distinguishes NAD+- vs NADP+-dependent activities in the same organism |
| ALDH5A1 (human) | Mitochondrial NAD+-dependent succinate semialdehyde dehydrogenase | Disease gene for succinic semialdehyde dehydrogenase deficiency; active-site network studied |
| SSADH (Rhodopseudomonas spheroides) | Succinate semialdehyde dehydrogenase active with both NADP+ and NAD+ | Early example of cofactor promiscuity |
| Potato tuber SSADH | Plant succinate semialdehyde dehydrogenase | Purification and characterization from plant tissue |
| YneI (Salmonella typhimurium) | NAD(P)+-dependent succinate semialdehyde dehydrogenase | Structural and activity studies of a bacterial homolog |
| gabT (context) | GABA transaminase producing succinate semialdehyde | Upstream enzyme supplying substrate for GO:0004777 |
| gabP (context) | GABA permease | Uptake of GABA for catabolism in bacteria |
| ssdA (context) | Succinate semialdehyde dehydrogenase in some bacteria | Alternative gene name for the activity |
| ALDH5A1 variants | Missense mutations affecting catalysis or NAD+ binding | Genotype-phenotype studies in SSADH deficiency |
| NAD+ pool genes (context) | Maintain NAD+ availability | Modulate flux through NAD+-dependent dehydrogenases |
| TCA cycle genes (context) | Consume succinate produced by the reaction | Link GO:0004777 to energy metabolism |
| GABA shunt genes (context) | Provide and consume GABA-related metabolites | Pathway context for the activity |
| Aldehyde dehydrogenase superfamily members | Share catalytic cysteine and Rossmann fold | Comparative enzymology of GO:0004777 |
| yneI homologs in other bacteria | Potential NAD+-dependent SSADH | Genome mining and functional assignment |
| ALDH5A1 orthologs in model organisms | Conserved GABA catabolism | Model system studies of the activity |
How Is succinate-semialdehyde dehydrogenase (NAD+) activity Regulated?
The activity of succinate-semialdehyde dehydrogenase (NAD+) is regulated at multiple levels. In Escherichia coli, the expression of genes encoding NAD+- and NADP+-dependent succinate semialdehyde dehydrogenases is influenced by the availability of GABA and succinate semialdehyde as carbon and nitrogen sources, and the two enzymes allow metabolic flexibility. In humans, ALDH5A1 is a mitochondrial enzyme whose catalysis depends on an active-site network of titratable residues that guides NAD+ binding; mutations in this network alter catalytic efficiency. Because the reaction consumes NAD+ and produces NADH, its flux is also sensitive to the cellular redox state and the availability of NAD+. Adaptive laboratory evolution experiments have shown that the promiscuous activity of succinate semialdehyde dehydrogenase can be recruited under selective pressure to repair metabolic deficiencies, indicating that its physiological role can be rewired by regulatory and metabolic changes.
succinate-semialdehyde dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH5A1 | Succinic semialdehyde dehydrogenase deficiency; accumulation of succinate semialdehyde and 4-hydroxybutyrate | Knockout or point-mutation cell models to measure enzyme activity and metabolite levels |
| ALDH5A1 active-site variants | Altered catalysis and NAD+ binding | Knock-in of patient variants followed by NADH production assays |
| yneI (E. coli) | GABA catabolism and metabolic deficiency repair | Knockout and adaptive laboratory evolution in E. coli |
| gabD (E. coli) | NADP+-dependent succinate semialdehyde oxidation | Comparative knockout to distinguish NAD+ vs NADP+ contributions |
| GABA shunt genes | Neurological and metabolic phenotypes | Overexpression or knockout in neuronal cell models |
Succinic semialdehyde dehydrogenase deficiency
In humans, loss of ALDH5A1-encoded succinate-semialdehyde dehydrogenase (NAD+) activity causes succinic semialdehyde dehydrogenase deficiency, a rare neurometabolic disorder. Impaired oxidation of succinate semialdehyde leads to its accumulation and to increased production of 4-hydroxybutyrate, which is associated with neurological dysfunction. The active-site network of titratable residues in human ALDH5A1 is critical for catalysis and NAD+ binding, and mutations affecting this network can reduce enzyme activity.
GABA metabolism and neurological function
GO:0004777 is a key step in the GABA catabolic pathway, converting succinate semialdehyde derived from GABA transamination to succinate. When this activity is reduced, the balance of GABA and its metabolites is disturbed, which can affect neuronal excitability and energy metabolism. The mitochondrial localization of human ALDH5A1 links the activity to mitochondrial redox and energy production.
Microbial metabolism and metabolic engineering
In bacteria, NAD+-dependent succinate semialdehyde dehydrogenase activity supports growth on GABA and succinate semialdehyde and contributes to succinate production. The experimental assignment of yneI as an NAD+/NADP+-dependent succinate semialdehyde dehydrogenase in Escherichia coli has clarified how this activity is encoded. Adaptive laboratory evolution has shown that the promiscuous activity of this enzyme can be recruited to repair different metabolic deficiencies, which is relevant for metabolic engineering.
From succinate-semialdehyde dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ALDH5A1 reduce NAD+-dependent succinate semialdehyde dehydrogenase activity? | ALDH5A1 knockout cell line with NADH production assay |
| Do patient variants alter catalysis or NAD+ binding? | Point-mutation knock-in of ALDH5A1 variants |
| Can the enzyme be tagged for localization studies? | Knock-in of fluorescent or affinity tag at the endogenous locus |
| Does overexpression increase flux through the GABA shunt? | Overexpression of ALDH5A1 or yneI in cell models |
| Which genes are required for growth on GABA? | CRISPR library screening in bacteria or mammalian cells |
| Can promiscuous activity be recruited to repair metabolic defects? | Adaptive laboratory evolution combined with knockout/overexpression |
How to Study the succinate-semialdehyde dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | NADH formation at 340 nm | Enzyme kinetics and inhibitor testing |
| Histochemistry | In situ enzyme activity | Tissue distribution studies |
| Gene knockout | Loss of gene function | Assigning genes to the activity |
| Overexpression | Increased enzyme levels | Flux and phenotype analysis |
| Site-directed mutagenesis | Effect of specific residues | Mechanistic studies of catalysis |
| Metabolomics | Succinate semialdehyde, succinate, 4-hydroxybutyrate | Disease and metabolic engineering |
| Structural biology | Active-site architecture | Cofactor binding and catalysis |
| Adaptive laboratory evolution | Emergence of compensatory mutations | Recruiting promiscuous activity |
Enzymatic activity assays
The NAD+-dependent oxidation of succinate semialdehyde can be measured spectrophotometrically by monitoring the formation of NADH at 340 nm. This assay has been used to characterize purified enzymes from bacteria, plants and humans. Histochemical methods for detecting succinate semialdehyde dehydrogenase activity in tissue sections have also been described, although methodological problems require careful controls.
Genetic and genomic approaches
Computational prediction combined with experimental verification has been used to assign the gene encoding NAD+/NADP+-dependent succinate semialdehyde dehydrogenase in Escherichia coli. Knockout and overexpression studies can link specific genes to the activity, and adaptive laboratory evolution can reveal alternative metabolic routes that recruit the enzyme's promiscuous activity.
Structural and mechanistic studies
Crystal structures and site-directed mutagenesis have revealed the active-site architecture of succinate semialdehyde dehydrogenases, including the catalytic cysteine and the network of titratable residues that guides NAD+ binding in the human enzyme. These studies help explain how mutations affect catalysis and cofactor specificity.
Metabolite profiling
Because the reaction produces succinate and consumes succinate semialdehyde, metabolomic profiling of these metabolites and related compounds such as 4-hydroxybutyrate can report on pathway flux. Such measurements are relevant to succinic semialdehyde dehydrogenase deficiency and to microbial metabolic engineering.
How CRISPR Can Be Used to Study GO:0004777 succinate-semialdehyde dehydrogenase (NAD+) activity
Knockout
CRISPR knockout of ALDH5A1 or bacterial yneI can eliminate NAD+-dependent succinate semialdehyde dehydrogenase activity, allowing researchers to measure the consequences for GABA catabolism, succinate production and redox balance. Knockout cell lines are useful for testing whether a candidate gene is required for the activity.
Point Mutation
Point mutations in the active-site network of human ALDH5A1 can be introduced by CRISPR to study how specific titratable residues guide catalysis and NAD+ binding. Such models help distinguish loss-of-function variants from benign polymorphisms.
Knock-in
Knock-in of tags or reporter sequences at the endogenous ALDH5A1 locus enables localization and interaction studies while preserving native regulation. Knock-in of disease-associated variants can recreate patient-specific enzyme defects.
Overexpression
Overexpression of ALDH5A1, yneI or homologs can increase flux through the succinate semialdehyde oxidation step, which is useful for metabolic engineering and for testing whether the enzyme is rate-limiting.
How EDITGENE Supports succinate-semialdehyde dehydrogenase (NAD+) activity Research
Researchers studying succinate-semialdehyde dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in the observed enzymatic activity, metabolite flux or disease phenotype. EDITGENE provides CRISPR-based cell model services that enable precise manipulation of genes such as ALDH5A1, yneI and gabD, from complete knockout to single-base correction, so that functional conclusions rest on well-controlled experiments.
Contact EDITGENE today to design your custom CRISPR model for succinate-semialdehyde dehydrogenase (NAD+) activity research.
Frequently Asked Questions About succinate-semialdehyde dehydrogenase (NAD+) activity
What is succinate-semialdehyde dehydrogenase (NAD+) activity?
It is the molecular function defined by GO:0004777, catalyzing the reaction succinate semialdehyde + NAD+ + H2O = succinate + NADH + H+.
What genes are involved in succinate-semialdehyde dehydrogenase (NAD+) activity?
Key genes include yneI and gabD in Escherichia coli and ALDH5A1 in humans, with additional homologs in plants and other bacteria.
What is the difference between NAD+ and NADP+ dependent succinate semialdehyde dehydrogenase?
Escherichia coli has separate NAD+- and NADP+-specific enzymes, while some homologs such as YneI can use both cofactors.
What disease is linked to succinate-semialdehyde dehydrogenase deficiency?
Loss of human ALDH5A1 activity causes succinic semialdehyde dehydrogenase deficiency, with accumulation of succinate semialdehyde and 4-hydroxybutyrate.
How is succinate-semialdehyde dehydrogenase activity measured?
It is commonly measured by monitoring NADH formation at 340 nm, and histochemical methods have also been described.
Where is succinate-semialdehyde dehydrogenase (NAD+) activity located in cells?
In humans, the orthologous enzyme ALDH5A1 is mitochondrial, linking the activity to mitochondrial metabolism.
Can CRISPR be used to study succinate-semialdehyde dehydrogenase (NAD+) activity?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can be used to manipulate genes such as ALDH5A1 and yneI.
What is the role of succinate-semialdehyde dehydrogenase in GABA metabolism?
It converts succinate semialdehyde derived from GABA transamination to succinate, which can enter the tricarboxylic acid cycle.
Is succinate-semialdehyde dehydrogenase activity found in bacteria?
Yes, bacteria such as Escherichia coli and Rhodopseudomonas spheroides possess NAD+- and/or NADP+-dependent succinate semialdehyde dehydrogenases.
How can adaptive laboratory evolution affect succinate-semialdehyde dehydrogenase?
Adaptive laboratory evolution can recruit the promiscuous activity of succinate semialdehyde dehydrogenase to repair different metabolic deficiencies.
Conclusion
GO:0004777 succinate-semialdehyde dehydrogenase (NAD+) activity is a well-defined molecular function that links GABA catabolism, redox balance and mitochondrial energy metabolism. Its catalytic mechanism, cofactor preferences and gene assignments have been characterized in bacteria, plants and humans, and its dysfunction is associated with neurological disease. For researchers, precise CRISPR models of genes such as ALDH5A1 and yneI provide a direct route to test causality, dissect active-site chemistry and explore metabolic engineering applications. Combining enzymatic assays, metabolomics and genome editing will continue to clarify how this activity contributes to health and disease.
References
- 1. Zheng H et al.. 2013. Structure and activity of the NAD(P)+-dependent succinate semialdehyde dehydrogenase YneI from Salmonella typhimurium.. Proteins 81(6):1031-41 PMID: 23229889
- 2. Cozzani I et al.. 1980. Separation and characterization of NAD- and NADP-specific succinate-semialdehyde dehydrogenase from Escherichia coli K-12 3300.. Biochim Biophys Acta 613(2):309-17 PMID: 7004491
- 3. Bernocchi G et al.. 1983. Methodological problems in the histochemical demonstration of succinate semialdehyde dehydrogenase activity.. Histochem J 15(12):1161-76 PMID: 6643116
- 4. Fuhrer T et al.. 2007. Computational prediction and experimental verification of the gene encoding the NAD+/NADP+-dependent succinate semialdehyde dehydrogenase in Escherichia coli.. J Bacteriol 189(22):8073-8 PMID: 17873044
- 5. He H et al.. 2024. Adaptive laboratory evolution recruits the promiscuity of succinate semialdehyde dehydrogenase to repair different metabolic deficiencies.. Nat Commun 15(1):8898 PMID: 39406738
- 6. Cesaro S et al.. 2025. A crucial active site network of titratable residues guides catalysis and NAD(+) binding in human succinic semialdehyde dehydrogenase.. Protein Sci 34(1):e70024 PMID: 39731543
- 7. Satya Narayan V et al.. 1989. Potato tuber succinate semialdehyde dehydrogenase: purification and characterization.. Arch Biochem Biophys 275(2):469-77 PMID: 2596851
- 8. Yambe R et al.. 1971. Succinate semialdehyde dehydrogenase of Rhodopseudomonas spheroides which is active with both NADP + and NAD + .. J Biochem 70(2):243-7 PMID: 4398452
